
. A significant breakthrough reveals one-third of cerebral palsy cases possess underlying genetic origins, closely linked to neurodevelopmental disorders like autism and epilepsy. Early genomic testing offers comprehensive diagnostic opportunities, promoting personalized treatment plans and timely interventions. Experts advocate integrating genomic testing into routine diagnostic procedures to enhance early clinical diagnoses and cater to individualized care for cerebral palsy patients.
Like
Save
Share